Many DTx companies target payers to get reimbursed, but very few vendors get what they are looking for. The process is not as straightforward as it is for drugs, and on top of that, DTx is becoming a more crowded and mature industry, making it harder to demonstrate value over competitors. Therefore, it is critical to have a good understanding of the payer’s needs and motivations to have a more focused and effective market access strategy.
How can DTx vendors build a value proposition that addresses payers’ pain points? Join other senior leaders in this meeting to deep dive into the following:
Understanding the different payer archetypes, their business drivers, motivations and needs. What capabilities does the DTx company need to conduct that research efficiently?
What are payers’ most common pain points? How do these vary depending on the type of payer, the geography, their populations, etc.?
How can DTx companies optimize the structure of their story to tailor their narrative and maximize impact when talking to payers?
Data points DTx companies need to show their value proposition. How can they show long-term cost reductions when they have been in the market for a short time?
What are the most appealing pricing models for both DTx and payers (e.g. pay per monthly user, pay per healthcare cost reduction, etc.)?
Differentiation from competitors. Best practices for DTx companies to build a value proposition that stands out from the crowd.
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.